Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;21(7):1836-1845.
doi: 10.1007/s10461-016-1580-x.

The Association Between Changes in Alcohol Use and Changes in Antiretroviral Therapy Adherence and Viral Suppression Among Women Living with HIV

Affiliations

The Association Between Changes in Alcohol Use and Changes in Antiretroviral Therapy Adherence and Viral Suppression Among Women Living with HIV

Nikita Barai et al. AIDS Behav. 2017 Jul.

Abstract

Heavy alcohol use has adverse effects in women with HIV. We examined the association between changes in alcohol use (measured with Timeline Followback) and changes in antiretroviral therapy adherence (medication possession ratio) and viral suppression (HIV RNA), measured over 6-month intervals. Among women who were (1) non-adherent or not virologically suppressed and (2) infrequent binge drinkers or non-heavy drinkers at baseline, increasing drinking was significantly associated with lower odds of subsequently improving adherence or viral suppression (OR of becoming adherent of 0.90 in infrequent binge drinkers; OR of becoming suppressed of 0.81 and 0.75 in infrequent binge drinkers and non-heavy drinkers, respectively). Our findings suggest that for these women, increasing drinking may be a barrier to achieving viral suppression. Addressing this barrier by integrating proactive alcohol counseling strategies into routine HIV care may be key to improving viral suppression rates among women retained in HIV care.

Keywords: Alcohol; Antiretroviral medication adherence; HIV infection; Viral load; Women.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Dr. Barai declares that she has no conflict of interest. Dr. Monroe declares that she has no conflict of interest. Dr. Lesko declares that she has no conflict of interest. Dr. Lau declares that he has no conflict of interest. Dr. Hutton declares that she has no conflict of interest. Dr. Yang declares that she has no conflict of interest. Dr. Alvanzo declares that she has no conflict of interest. Dr. McCaul declares that she has no conflict of interest. Dr. Chander declares that she has no conflict of interest.

Similar articles

Cited by

References

    1. CDC. HIV Among Women. Avaiable at: http://www.cdc.gov/hiv/group/gender/women/. Accessed: January 11, 2016.
    1. Fagbami O, Oluwasanjo A, Fitzpatrick C, Fairchild R, Shin A, Donato A. Factors supporting and inhibiting adherence to HIV medication regimen in women: a qualitative analysis of patient interviews. Open AIDS J. 2015;9:45–50. - PMC - PubMed
    1. Cohen MH, Cook JA, Grey D, et al. Medically eligible women who do not use HAART: the importance of abuse, drug use, and race. Am J Public Health. 2004;94(7):1147–51. - PMC - PubMed
    1. Turner BJ, Laine C, Cosler L, Hauck WW. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV‐infected drug users. J Gen Intern Med. 2003;18(4):248–57. - PMC - PubMed
    1. Murphy DA, Greenwell L, Hoffman D. Factors associated with antiretroviral adherence among HIV-infected women with children. Women Health. 2002;36(1):97–111. - PubMed

LinkOut - more resources